Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Audience Unimpressed By Verve’s Base Playing

Nov 16 2023

• By Elizabeth Cairns

Verve Therapeutics

Related Content

Deal Watch: Lilly Will Take Over Beam’s Rights To Verve Cardiovascular Assets

Nov 01 2023

Verve’s Cholesterol Gene Editing Hits Milestone – With Lilly Now Onboard

Nov 13 2023

A Look At Leqvio’s Lacklustre Launch

Jul 26 2023

Related Companies

Vertex Pharmaceuticals Incorporated

Verve Therapeutics, Inc.

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Novartis AG

Merck & Co., Inc.

AstraZeneca PLC

Additional Topics

Clinical Trials Safety Companies Research & Development Cardiovascular BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.